✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Share

Global Disease Challenges

hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.

Global Disease Challenges

expand

Our Aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.

5-Year Target: 175 million individuals will have benefited from Johnson & Johnson solutions that prevent, control and eliminate global diseases.

Status: Exceeded

Our Impact:

• How a Small Chewable Tablet Is Helping Tackle a Disease That Impacts Nearly 1 Billion Children Globally

• New Horizons Collaborative: Addressing Needs of Children Impacted by HIV

• As 2030 Deadline Looms We Must Accelerate Progress Against TB

Global Mental Health
& Well-Being

Our Mission to End HIV

Enabling a World Without TB

Enabling a World Without TB

India

How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

Two smiling young girls

Johnson & Johnson's COVID-19 Vaccine

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

Dr. Paul Stoffels, Johnson & Johnson Chief Scientific Officer, at 2017 Global Citizen Festival

Ending MDR-TB: “It’s Doable. Let’s Solve It”

Ending MDR-TB: “It’s Doable. Let’s Solve It”

The Global Fund, Stop TB, The Economist and WEF joined Johnson & Johnson in the coLaboratory for the Future

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

The New Ebola Clinical Trial That's Focused on Helping Halt Future Outbreaks

The New Ebola Clinical Trial That's Focused on Helping Halt Future Outbreaks

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections

U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

Unseen Enemy: The New Film That Looks at Why Viruses Like Zika, Ebola and Influenza Are So Prevalent

Unseen Enemy: The New Film That Looks at Why Viruses Like Zika, Ebola and Influenza Are So Prevalent

Johnson & Johnson Teams Up With Health Officials Across Brazil to Fight Zika

Johnson & Johnson Teams Up With Health Officials Across Brazil to Fight Zika

The Janssen Pharmaceutical Companies of Johnson & Johnson Partner on an Ambitious Tuberculosis Program in India

The Janssen Pharmaceutical Companies of Johnson & Johnson Partner on an Ambitious Tuberculosis Program in India

Our 2030 Promise

Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.

Learn More About Our Initial 5-Year SDG Commitment (2016 – 2020)

More From Johnson & Johnson

Caring & Giving

The Story Behind BAND-AID^®Brand OURTONE™ Adhesive Bandages

The Story Behind BAND-AID^®Brand OURTONE™ Adhesive Bandages

The launch of the new OURTONE™ strips, which come in three brown shades, means more bandage options for communities of color—and scholarship support for Black nursing students.

Latest News

5 Ways Johnson & Johnson Is Working to Improve the Well-Being of the World by 2025

5 Ways Johnson & Johnson Is Working to Improve the Well-Being of the World by 2025

Johnson & Johnson's 2020 Health for Humanity Report details the progress it's made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company's looking ahead to the next five.

Members of a Johnson & Johnson HIV prevention program in South Africa

Innovation

Quiz: How Much Do You Really Know About COVID-19?

Quiz: How Much Do You Really Know About COVID-19?

Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.

Virus graphic